Free Trial

Madrigal Pharmaceuticals (MDGL) Short Interest Ratio & Short Volume

Madrigal Pharmaceuticals logo
$410.14 +3.05 (+0.75%)
As of 01:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Madrigal Pharmaceuticals Short Interest Data

Madrigal Pharmaceuticals (MDGL) has a short interest of 3.98 million shares, representing 22.84% of the float (the number of shares available for trading by the public). This marks a 5.01% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.5, indicating that it would take 11.5 days of the average trading volume of 381,391 shares to cover all short positions.

Current Short Interest
3,980,000 shares
Previous Short Interest
3,790,000 shares
Change Vs. Previous Month
+5.01%
Dollar Volume Sold Short
$1.20 billion
Short Interest Ratio
11.5 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
22,203,000 shares
Short Percent of Float
22.84%
Today's Trading Volume
263,116 shares
Average Trading Volume
381,391 shares
Today's Volume Vs. Average
69%
Short Selling Madrigal Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MDGL Short Interest Over Time

MDGL Days to Cover Over Time

MDGL Percentage of Float Shorted Over Time

Madrigal Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20253,980,000 shares $1.20 billion +5.0%22.8%11.5 $302.51
7/15/20253,790,000 shares $1.18 billion -4.5%N/A11.2 $311.14
6/30/20253,970,000 shares $1.20 billion -4.3%22.8%11.9 $302.64
6/15/20254,150,000 shares $1.23 billion +6.7%23.8%12.6 $295.57
5/31/20253,890,000 shares $1.08 billion -2.8%23.1%11.6 $276.70
5/15/20254,000,000 shares $1.17 billion -2.4%23.8%10.7 $291.82
4/30/20254,100,000 shares $1.37 billion +1.7%N/A11 $333.91
4/15/20254,030,000 shares $1.29 billion +0.8%23.9%10.7 $321.10
3/31/20254,000,000 shares $1.32 billion -2.2%23.8%9.9 $331.23
3/15/20254,090,000 shares $1.42 billion +9.1%24.3%10.1 $348.35
2/28/20253,750,000 shares $1.28 billion -1.3%22.3%9.3 $341.27
2/15/20253,800,000 shares $1.28 billion -4.5%22.6%9.8 $337.20
1/31/20253,980,000 shares $1.33 billion -2.5%N/A9.9 $334.80
1/15/20254,080,000 shares $1.12 billion -0.7%N/A8.6 $274.41
12/31/20244,110,000 shares $1.27 billion -13.1%N/A9.8 $308.57
12/15/20244,730,000 shares $1.44 billion +10.5%N/A11.2 $304.50
11/30/20244,280,000 shares $1.40 billion -3.4%N/A10.6 $328.19
11/15/20244,430,000 shares $1.28 billion -2.2%N/A11.3 $288.58
10/31/20244,530,000 shares $1.17 billion +11.9%N/A13.1 $259.34
10/15/20244,050,000 shares $875.49 million +4.9%N/A15.1 $216.17
9/30/20243,860,000 shares $819.17 million +3.5%N/A13.8 $212.22
9/15/20243,730,000 shares $901.91 million -0.8%N/A13.5 $241.80
8/31/20243,760,000 shares $929.21 million +0.3%N/A11.5 $247.13
8/15/20243,750,000 shares $916.88 million +1.9%N/A9.5 $244.50
7/31/20243,680,000 shares $1.05 billion -10.5%N/A8.6 $284.66
7/15/20244,110,000 shares $1.15 billion +0.7%N/A9.1 $279.95
6/30/20244,080,000 shares $1.14 billion -7.9%N/A9.1 $280.16
6/15/20244,430,000 shares $1.23 billion -15.3%N/A9.5 $277.59
5/31/20245,230,000 shares $1.24 billion +25.4%N/A9.4 $236.16
5/15/20244,170,000 shares $882.91 million +4.8%N/A8.1 $211.73
4/30/20243,980,000 shares $812.00 million +16.7%N/A6.9 $204.02
4/15/20243,410,000 shares $788.97 million +1.5%N/A5.9 $231.37
3/31/20243,360,000 shares $897.25 million +3.1%N/A6 $267.04
3/15/20243,260,000 shares $881.41 million -5.8%20.2%5.9 $270.37
2/29/20243,460,000 shares $817.25 million +2.1%21.4%7.3 $236.20
2/15/20243,390,000 shares $753.33 million +8.0%21.1%7.6 $222.22
1/31/20243,140,000 shares $680.47 million -5.1%19.5%7.2 $216.71
1/15/20243,310,000 shares $780.50 million +1.9%21.1%8.6 $235.80
12/31/20233,250,000 shares $751.99 million +5.9%20.7%7.9 $231.38
12/15/20233,070,000 shares $727.99 million -11.5%19.5%6.7 $237.13
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
11/30/20233,470,000 shares $705.45 million +0.3%24.4%7.1 $203.30
11/15/20233,460,000 shares $559.41 million +1.5%24.3%7.7 $161.68
10/31/20233,410,000 shares $448.01 million +13.3%24.7%8.2 $131.38
10/15/20233,010,000 shares $422.51 million +13.6%21.8%7.6 $140.37
9/30/20232,650,000 shares $387.01 million +24.4%19.2%7.4 $146.04
9/15/20232,130,000 shares $374.65 million +8.7%16.5%6.3 $175.89
8/31/20231,960,000 shares $352.80 million +8.3%15.2%6.3 $180.00
8/15/20231,810,000 shares $315.25 million -1.1%14.0%5.7 $174.17
7/31/20231,830,000 shares $375.70 million -3.2%13.8%5.3 $205.30
7/15/20231,890,000 shares $426.71 million +7.4%14.3%5.4 $225.77
6/30/20231,760,000 shares $406.56 million +10.0%13.3%4.7 $231.00
6/15/20231,600,000 shares $408.85 million +10.3%12.1%4.7 $255.53
5/31/20231,450,000 shares $403.69 million +15.1%10.4%3.9 $278.41
5/15/20231,260,000 shares $365.77 million -8.7%9.0%3.1 $290.29
4/30/20231,380,000 shares $430.56 million -6.8%10.0%3.3 $312.00
4/15/20231,480,000 shares $354.89 million +19.4%10.8%3.7 $239.79
3/31/20231,240,000 shares $300.40 million +3.3%9.2%3.1 $242.26
3/15/20231,200,000 shares $286.57 million +16.5%8.7%2.3 $238.81
2/28/20231,030,000 shares $279.14 million +9.2%7.4%1.6 $271.01
2/15/2023942,900 shares $266.14 million 0.0%7.2%1.5 $282.26
1/31/2023943,300 shares $271.91 million -3.3%7.2%1.6 $288.25
1/15/2023975,300 shares $292.57 million -12.9%7.5%1.6 $299.98
12/30/20221,120,000 shares $325.08 million -52.7%9.0%1.9 $290.25
12/15/20222,370,000 shares $149.07 million +9.7%19.1%4.3 $62.90
11/30/20222,160,000 shares $151.44 million +3.9%17.4%7.3 $70.11
11/15/20222,080,000 shares $146.68 million +14.3%16.8%7.9 $70.52
10/31/20221,820,000 shares $128.89 million +17.4%14.7%7.4 $70.82
10/15/20221,550,000 shares $100.27 million +1.3%12.5%6.6 $64.69
9/30/20221,530,000 shares $99.43 million +2.7%12.4%7.2 $64.99
9/15/20221,490,000 shares $103.70 million +1.4%12.1%7.4 $69.60
8/31/20221,470,000 shares $106.02 million -4.6%11.9%7.8 $72.12
8/15/20221,540,000 shares $118.13 million -3.8%12.5%8.6 $76.71
7/31/20221,600,000 shares $100.51 million +3.2%12.9%8.4 $62.82
7/15/20221,550,000 shares $107.24 million -4.3%12.5%8.1 $69.19
6/30/20221,620,000 shares $115.96 million -2.4%13.1%8.1 $71.58
6/15/20221,660,000 shares $112.71 million +3.8%13.4%8.6 $67.90
5/31/20221,600,000 shares $106.22 million -5.3%12.9%8.5 $66.39
5/15/20221,690,000 shares $111.08 million -2.9%13.6%8.8 $65.73
4/30/20221,740,000 shares $121.80 million +1.8%14.0%8.2 $70.00
4/15/20221,710,000 shares $135.89 million -5.5%13.8%7.3 $79.47
3/31/20221,810,000 shares $177.60 million -9.1%14.6%7.8 $98.12
3/15/20221,990,000 shares $179.10 million +0.5%16.0%8.5 $90.00
2/28/20221,980,000 shares $183.84 million -1.5%16.0%8.1 $92.85
2/15/20222,010,000 shares $180.72 million +12.3%16.2%8.4 $89.91
1/31/20221,790,000 shares $103.07 million +19.3%14.4%8.5 $57.58
1/15/20221,500,000 shares $117.68 million +8.7%12.1%9.4 $78.45
12/31/20211,380,000 shares $116.94 million -6.8%11.1%9.6 $84.74
12/15/20211,480,000 shares $110.82 million +7.3%11.9%10.8 $74.88
11/30/20211,380,000 shares $114.14 million +2.2%12.0%12 $82.71
11/15/20211,350,000 shares $122.00 million -3.6%11.8%12.7 $90.37
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
10/29/20211,400,000 shares $108.85 million +3.7%12.2%13.3 $77.75
10/15/20211,350,000 shares $116.33 million -6.9%12.1%13.5 $86.17
9/30/20211,450,000 shares $115.70 million No Change13.0%14.1 $79.79
9/15/20211,450,000 shares $115.10 million -7.1%13.0%11.9 $79.38
8/31/20211,560,000 shares $129.09 million -5.5%14.0%12.2 $82.75
8/13/20211,650,000 shares $140.02 million +3.1%14.8%10.9 $84.86
7/30/20211,600,000 shares $139.71 million -4.2%14.4%10.4 $87.32
7/15/20211,670,000 shares $157.95 million No Change15.0%11 $94.58
6/30/20211,670,000 shares $162.67 million -5.1%15.0%10.9 $97.41
6/15/20211,760,000 shares $185.66 million -7.9%15.8%12.4 $105.49
5/28/20211,910,000 shares $214.49 million -7.3%17.2%14.1 $112.30
5/14/20212,060,000 shares $271.12 million +1.0%18.9%16.5 $131.61
4/30/20212,040,000 shares $280.68 million -8.5%18.7%14.8 $137.59
4/15/20212,230,000 shares $269.70 million -5.1%21.8%12.3 $120.94
3/31/20212,350,000 shares $273.80 million -4.5%23.4%12.7 $116.51
3/15/20212,460,000 shares $289.89 million -7.5%24.5%12.4 $117.84
2/26/20212,660,000 shares $327.34 million -4.0%26.5%13.5 $123.06
2/12/20212,770,000 shares $334.67 million +5.3%28.6%14.4 $120.82
1/29/20212,630,000 shares $304.11 million -8.4%26.0%13.7 $115.63
1/15/20212,870,000 shares $327.18 million +4.7%28.4%17.9 $114.00
12/31/20202,740,000 shares $304.47 million +12.3%27.1%19.3 $111.12
12/15/20202,440,000 shares $294.58 million -2.4%24.2%17.2 $120.73
11/30/20202,500,000 shares $297.78 million +5.5%24.8%16.9 $119.11
11/15/20202,370,000 shares $303.57 million -4.4%23.5%16.3 $128.09
10/30/20202,480,000 shares $318.23 million +0.8%24.6%18.5 $128.32
10/15/20202,460,000 shares $312.94 million No Change24.4%19.1 $127.21
9/30/20202,460,000 shares $292.08 million -13.7%24.4%19.4 $118.73
9/15/20202,850,000 shares $304.72 million +2.5%28.3%21.4 $106.92
8/31/20202,780,000 shares $299.41 million -1.8%27.6%25 $107.70

MDGL Short Interest - Frequently Asked Questions

What is Madrigal Pharmaceuticals' current short interest?

Short interest is the volume of Madrigal Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 3,980,000 shares of MDGL short. 22.84% of Madrigal Pharmaceuticals' shares are currently sold short. Learn More on Madrigal Pharmaceuticals' current short interest.

What is a good short interest ratio for Madrigal Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDGL shares currently have a short interest ratio of 12.0. Learn More on Madrigal Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Madrigal Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Madrigal Pharmaceuticals: Nomura Holdings Inc., Group One Trading LLC, 683 Capital Management LLC, Jane Street Group LLC, Walleye Capital LLC, Garda Capital Partners LP, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Madrigal Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.84% of Madrigal Pharmaceuticals' floating shares are currently sold short.

Is Madrigal Pharmaceuticals' short interest increasing or decreasing?

Madrigal Pharmaceuticals saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 3,980,000 shares, an increase of 5.0% from the previous total of 3,790,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Madrigal Pharmaceuticals' short interest compare to its competitors?

22.84% of Madrigal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Madrigal Pharmaceuticals: Biogen Inc. (2.71%), Incyte Corporation (3.85%), United Therapeutics Corporation (3.56%), Neurocrine Biosciences, Inc. (3.02%), BioMarin Pharmaceutical Inc. (2.71%), Exelixis, Inc. (6.67%), Exact Sciences Corporation (3.68%), Halozyme Therapeutics, Inc. (8.58%), Ionis Pharmaceuticals, Inc. (7.45%), Repligen Corporation (6.84%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Madrigal Pharmaceuticals stock?

Short selling MDGL is an investing strategy that aims to generate trading profit from Madrigal Pharmaceuticals as its price is falling. MDGL shares are trading up $11.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Madrigal Pharmaceuticals?

A short squeeze for Madrigal Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MDGL, which in turn drives the price of the stock up even further.

How often is Madrigal Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDGL, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:MDGL) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners